Bladder cancer patients over 70 less likely to get curative treatment

April 17, 2013, Cancer Research UK

(Medical Xpress)—Older bladder cancer patients are less likely than younger patients to receive treatments intended to cure their disease such as surgery to remove the bladder or radiotherapy. But this difference cannot be fully explained by age, according to new research by scientists published in the British Journal of Cancer.

Researchers, funded by Yorkshire at the University of Sheffield, looked at the records of around 3,300 bladder cancer patients diagnosed in Sheffield between 1994 and 2009. They wanted to investigate how age, type of bladder cancer and treatment affected the chances of surviving the disease2.

They found that 52 per cent of patients under 60 had potentially curative treatments such as surgery or radiotherapy, compared with 34 per cent of patients in their 70s and only 12 per cent of patients over 80.

And older patients over 70 were more likely to die of their bladder cancer than younger patients.

The researchers believe that the higher number of deaths in those over 70 is because these patients had a higher proportion of more aggressive tumours and were less likely to receive radical treatments such as or surgery to remove the bladder and nearby organs.

Mr James Catto, study author and consultant urological surgeon at the University of Sheffield, said: "Even though it appears that older patients are more likely to have aggressive tumours, our findings suggest that not enough older patients are being offered treatments that could increase their chance of survival.

"What's very worrying is this conservative approach to treating older patients appears to be affecting the life expectancy of this group, something that doctors must work hard to combat."

Dr Kathryn Scott, head of research funding at Yorkshire Cancer Research, said: "This research shows that the age of bladder in Sheffield greatly affects how they are treated. This has a considerable effect on in elderly patients and Yorkshire, along with the rest of the UK, is going to have to change to address this striking difference."

Sarah Woolnough, executive director of policy and information at Cancer Research UK, said: "This study shows the older the patients are the less likely they are to be offered the kind of treatments that could cure their cancer.

"These decisions are never easy and need to be balanced with quality of life but it's vital for patients of all ages to be given the option of a possible cure when it is still feasible."

Explore further: Adding chemo to radiotherapy halves risk of deadly bladder cancer returning

More information: Noon, A. et al. (2013). Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients British Journal of Cancer DOI: 10.1038/bjc.2013.106

Related Stories

Adding chemo to radiotherapy halves risk of deadly bladder cancer returning

April 23, 2012
(Phys.org) -- Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy ...

Multi-tasking imatinib boosts radiotherapy for bladder tumours

March 4, 2013
Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research.

Chemo - radiation best for bladder cancer, study finds

April 19, 2012
(HealthDay) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy led to significantly longer survival rates among patients with muscle-invasive bladder cancer.

Elderly breast cancer patients less likely to get surgery

June 17, 2011
(PhysOrg.com) -- University of Manchester researchers, working with colleagues in York, Leeds and Hull, looked at the records of more than 23,000 women with breast cancer diagnosed in the West Midlands, Yorkshire and North ...

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.